Kymera Therapeutics, Inc.
NASDAQ: KYMR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Nello Mainolfi
- Employees
- 208
- Headquarters
- Watertown, United States
- IPO year
- 2020
- Market cap
- $7.4B
- Website
- https://www.kymeratx.com
Loading KYMR…
Loading profile data…Frequently asked questions about KYMR
What does Kymera Therapeutics, Inc. (KYMR) do?
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 pro...
Where does KYMR trade?
Kymera Therapeutics, Inc. (KYMR) trades on the NASDAQ Global Market.
What sector is KYMR in?
Kymera Therapeutics, Inc. (KYMR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kymera Therapeutics, Inc.?
Nello Mainolfi is the chief executive officer of Kymera Therapeutics, Inc. (KYMR).
Where is Kymera Therapeutics, Inc. headquartered?
Kymera Therapeutics, Inc. is headquartered in United States.
Does KYMR pay a dividend?
Kymera Therapeutics, Inc. (KYMR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KYMR go public?
Kymera Therapeutics, Inc. (KYMR) completed its initial public offering in 2020.